EC
CDAK

EcoR1 Capital’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History

EcoR1 Capital’s Portfolio CDAK Stock Details CDAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-115,195
Closed -$1.74M – 78
2021
Q1 		$1.74M Hold
115,195
– – 0.08% 57
2020
Q4 		$3.72M Buy
+115,195
New +$1.52M 0.2% 45

Other funds holding CDAK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
APF
Alaska Permanent Fund Juneau, Alaska $1.57B AUM 15.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EcoR1 Capital's CDAK Position: Q2 2021 in Review

EcoR1 Capital sold out of Codiak BioSciences, Inc. Common Stock (CDAK) in Q2 2021, closing a stake of 115,195 shares — an estimated $1.74M sold.

EcoR1 Capital first reported a position in CDAK in Q4 2020 and held it in 2 quarters. The position peaked at $3.72M in Q4 2020. 52 funds tracked by Wall St. Rank hold CDAK as of Q2 2021.

  • EcoR1 Capital reported no remaining Codiak BioSciences, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • EcoR1 Capital sold 115,195 Codiak BioSciences, Inc. Common Stock shares in Q2 2021, an estimated $1.74M.
  • EcoR1 Capital first reported a position in Codiak BioSciences, Inc. Common Stock in Q4 2020 and held it in 2 quarters.
  • EcoR1 Capital's Codiak BioSciences, Inc. Common Stock position peaked at $3.72M in Q4 2020.
  • 52 funds tracked by Wall St. Rank held Codiak BioSciences, Inc. Common Stock as of Q2 2021.

Based on EcoR1 Capital's 13F filing for Q2 2021, filed 16 Aug 2021.